Tag

BMWS22

Realizing Gilead’s 2030 Ambition: Advancing a Diverse Portfolio with a Complex Manufacturing Network
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Realizing Gilead’s 2030 Ambition: Advancing a Diverse Portfolio with a Complex Manufacturing Network

Gilead’s ambition is moving from a predominantly virology focused portfolio to a more diverse one with an emphasis on adding oncology and inflammation asset To accomplish this a wide net needed to be deployed to rapidly build a portfolio through external sourcing and internal innovation This has resulted in a diverse set of acquisitions, partnerships, opt-ins, and collaborations across program phases and modalities, resulting in a complex manufacturing network This talk will cover the strategies being deployed across the pillars of Process Development, Supply Chain, Quality, Regulatory, and External Manufacturing to realize Gilead’s 2030 ambition — Art Hewig VP of…

Continue reading
Sustainability for Process Development to Manufacturing: How Can We Leverage Digital Technology to Capture Quality and Productivity Efficiencies?
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Sustainability for Process Development to Manufacturing: How Can We Leverage Digital Technology to Capture Quality and Productivity Efficiencies?

The Control Tower: Providing visibility with actionable insights into the health of your manufacturing Yield Improvement: Process understanding and advanced modeling for significant ROI Digital twin: simulation and improved productivity by employing Smart Scheduling Successful industry 4.0 pharma use cases How to effectively build programs to deploy and maintain technology to continuously improve and capture value — Rick Johnston Sr. Director Applied Materials Rick is a senior technical leader within Applied Materials’ pharmaceutical business unit. He has more than 15 years of experience in building software that solves big data, machine learning, scheduling, forecasting and advanced analytics problems in pharma….

Continue reading
Acceleration of Clinical Timelines Using Azzur Cleanrooms on Demand™, a Novel Approach to Biopharmaceutical Manufacturing
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Acceleration of Clinical Timelines Using Azzur Cleanrooms on Demand™, a Novel Approach to Biopharmaceutical Manufacturing

Current industry challenges and opportunities related to biopharma manufacturing Internal manufacturing capability establishment challenges for biopharma Challenges related to outsourcing of technology and process throughout product lifecycle The Azzur Cleanrooms on Demand™ model Case Studies — Ravi Samavedam Chief Innovation Officer Azzur Group Ravi Samavedam is a Biochemical Engineer with more than 20 years of experience in the pharmaceutical and biotechnology industries. Ravi joined Azzur in 2012, and prior to his appointment as CINO of Azzur Group, Ravi was the President and COO of Azzur Cleanrooms on Demand™ and previously served as  General Manager of the Boston-area consulting practice.  Prior…

Continue reading
Establishing a ‘Culture of Data’ in Pharma Manufacturing
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Establishing a ‘Culture of Data’ in Pharma Manufacturing

Pharmaceutical manufacturers have worked diligently and successfully to foster a ‘culture of quality’, resulting in fewer overall regulatory citations year over year since 2010. How can better data management and analytics impact not only quality but process improvement and efficiency gains as well? What trends are driving the need to move towards both managing and using data better? The ‘culture of data’ starts with changing old ways of working. What steps do biopharma manufacturers need to take to initiate their transformation? How can manufacturers use manufacturing process data to quickly and proactively improve outcomes? — Vishaka Rajaram Director, Pharmaceutical and…

Continue reading